A radical plan by a former Trump aide seeks to encourage obese Americans to lose weight—by helping their wallet. Robert P.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...